

Vericel (NASDAQ:VCEL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Vericel (NASDAQ:VCEL) through any online brokerage.
Other companies in Vericel’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Vericel has a consensus price target of $62.14.
The stock price for Vericel (NASDAQ: VCEL) is $56.32 last updated November 6, 2026 at 6:55 PM EST.
There are no upcoming dividends for Vericel.
Vericel does not have any upcoming earnings scheduled.
There is no upcoming split for Vericel.
Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured...